Evidence map›Paper›PMID 24623416›Full record

ArticleJournal of virology2014

Factors associated with siman immunodeficiency virus transmission in a natural African nonhuman primate host in the wild.

Dongzhu Ma, Anna J Jasinska, Felix Feyertag, Viskam Wijewardana, Jan Kristoff, Tianyu He, Kevin Raehtz, Christopher A Schmitt, Yoon Jung, Jennifer Danzy Cramer and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 44 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 1 pooled it
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 1 synthesis or guideline pooled it, 89 citations in OpenAlex.

  1. The Hitchhiker Guide to CD4Frontiers in immunology · 2021
    Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 3 countries.

Dongzhu MaCenter for Vaccine Research, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Anna J Jasinska
Felix Feyertag
Viskam Wijewardana
Jan Kristoff
Tianyu He
Kevin Raehtz
Christopher A Schmitt
Yoon Jung
Jennifer Danzy Cramer
Michel Dione
Martin Antonio
Russell Tracy
Trudy Turner
David L Robertson
Ivona Pandrea
Nelson Freimer
Cristian Apetrei
International Vervet Research Consortium
University of Pittsburgh · USUniversity of California, Los Angeles · USMRC Unit the Gambia · GMUniversity of Manchester · GBAmerican Public University System · USUniversity of Vermont · USUniversity of Wisconsin–Milwaukee · US

Funding

Novel SIVsmm strains for analysis of mucosal transmission and vaccine protectionP01AI088564 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHAW, GEORGE M · 2010 to 2014
$12.7M
SIV Pathogenesis in African Green Monkeys and Pigtailed MacaquesR01HL117715 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI VASILE PANDREA, IVONA · 2012 to 2021
$7.0M
Vervet Monkey (Cercopithecus Aethiops) Genetic MapR01RR016300 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B. · 2002 to 2011
$6.3M
Animal Model for SIV Infection ControlR01RR025781 · NCRR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN, VASILE PANDREA, IVONA · 2009 to 2010
$1.9M
Integrated Genetic and Genomic Resources for a Model SystemR01OD010980 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI FREIMER, NELSON B. · 2012 to 2012
$741k
Early Events and Determinants of Oral SIV Transmission in Infant Nonhuman PrimateR56DE023508 · NIDCR · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI APETREI, CRISTIAN · 2013 to 2013
$372k
Biotechnology and Biological Sciences Research CouncilMedical Research CouncilNCRR NIH HHS R01 RR016300NCRR NIH HHS R01RR016300NCRR NIH HHS R01 RR025781NHLBI NIH HHS R01 HL117715NIAID NIH HHS P01 AI088564NIDCR NIH HHS R56 DE023508NIH HHS R01 OD010980NIH HHS R01OD010980
6 · The paper itself

Abstract

unlabelledAfrican green monkeys (AGMs) are naturally infected with simian immunodeficiency virus (SIV) at high prevalence levels and do not progress to AIDS. Sexual transmission is the main transmission route in AGM, while mother-to-infant transmission (MTIT) is negligible. We investigated SIV transmission in wild AGMs to assess whether or not high SIV prevalence is due to differences in mucosal permissivity to SIV (i.e., whether the genetic bottleneck of viral transmission reported in humans and macaques is also observed in AGMs in the wild). We tested 121 sabaeus AGMs (Chlorocebus sabaeus) from the Gambia and found that 53 were SIV infected (44%). By combining serology and viral load quantitation, we identified 4 acutely infected AGMs, in which we assessed the diversity of the quasispecies by single-genome amplification (SGA) and documented that a single virus variant established the infections. We thus show that natural SIV transmission in the wild is associated with a genetic bottleneck similar to that described for mucosal human immunodeficiency virus (HIV) transmission in humans. Flow cytometry assessment of the immune cell populations did not identify major differences between infected and uninfected AGM. The expression of the SIV coreceptor CCR5 on CD4+ T cells dramatically increased in adults, being higher in infected than in uninfected infant and juvenile AGMs. Thus, the limited SIV MTIT in natural hosts appears to be due to low target cell availability in newborns and infants, which supports HIV MTIT prevention strategies aimed at limiting the target cells at mucosal sites. Combined, (i) the extremely high prevalence in sexually active AGMs, (ii) the very efficient SIV transmission in the wild, and (iii) the existence of a fraction of multiparous females that remain uninfected in spite of massive exposure to SIV identify wild AGMs as an acceptable model of exposed, uninfected individuals. IMPORTANCE: We report an extensive analysis of the natural history of SIVagm infection in its sabaeus monkey host, the African green monkey species endemic to West Africa. Virtually no study has investigated the natural history of SIV infection in the wild. The novelty of our approach is that we report for the first time that SIV infection has no discernible impact on the major immune cell populations in natural hosts, thus confirming the nonpathogenic nature of SIV infection in the wild. We also focused on the correlates of SIV transmission, and we report, also for the first time, that SIV transmission in the wild is characterized by a major genetic bottleneck, similar to that described for HIV-1 transmission in humans. Finally, we report here that the restriction of target cell availability is a major correlate of the lack of SIV transmission to the offspring in natural hosts of SIVs.

Indexed as

AnimalsChlorocebus aethiopsCluster AnalysisFemaleFlow CytometryGambiaGenotypeLentivirus InfectionsLymphocyte SubsetsMaleMolecular Sequence DataMonkey DiseasesPhylogenySequence Analysis, DNASimian Immunodeficiency Virus

Identifiers

PMID24623416
PMCPMC4019088
OpenAlexW2157470619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.